Published in Am Heart J on March 14, 2008
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA (2013) 4.84
Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol (2009) 3.42
Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes (2010) 2.19
The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type. J Med Econ (2012) 0.95
Hospital volume, hospital teaching status, patient socioeconomic status, and outcomes in patients hospitalized with sickle cell disease. Am J Hematol (2011) 0.94
Diagnosis-specific readmission risk prediction using electronic health data: a retrospective cohort study. BMC Med Inform Decis Mak (2014) 0.83
Patients' annual income adequacy, insurance premiums and out-of-pocket expenses related to heart failure care. Heart Lung (2014) 0.83
Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure. Tex Heart Inst J (2017) 0.75
Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study. Cardiovasc Drugs Ther (2013) 0.75
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med (2010) 3.05
Early mobilization of patients hospitalized with community-acquired pneumonia. Chest (2003) 2.85
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant (2005) 2.76
Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis (2009) 2.74
Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission. Liver Transpl (2009) 2.38
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant (2003) 2.22
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant (2005) 2.19
Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17
Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol (2004) 1.93
The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl (2011) 1.79
Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol (2003) 1.77
Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation (2009) 1.75
Health insurance considerations for adolescent transplant recipients as they transition to adulthood. Pediatr Transplant (2007) 1.68
Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45
Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation. J Am Soc Nephrol (2008) 1.45
Reconsidering models of patient satisfaction and behavioral intentions. Health Care Manage Rev (2003) 1.43
Transplant certification and quality assessment: time to take the front line? Prog Transplant (2013) 1.43
Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States. Transplantation (2016) 1.42
Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant (2004) 1.33
The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes. Clin J Am Soc Nephrol (2010) 1.32
Using focus groups to understand physicians' and nurses' perspectives on error reporting in hospitals. Jt Comm J Qual Saf (2004) 1.29
Brief report: Hospitalized patients' attitudes about and participation in error prevention. J Gen Intern Med (2006) 1.28
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22
Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol (2008) 1.21
Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis (2008) 1.20
Digoxin use and digoxin toxicity in the post-DIG trial era. J Card Fail (2006) 1.19
Physician attitudes toward end-stage heart failure: a national survey. Am J Med (2008) 1.14
The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation. Transplantation (2012) 1.14
Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation (2006) 1.13
Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol (2006) 1.13
Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol (2005) 1.11
Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.10
De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis (2005) 1.09
Patient satisfaction: focusing on "excellent". J Healthc Manag (2009) 1.08
Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation (2004) 1.07
The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant (2004) 1.07
Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation (2007) 1.06
Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation (2014) 1.04
Novel methods for tracking long-term maintenance immunosuppression regimens. Clin J Am Soc Nephrol (2007) 1.04
Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med (2008) 1.03
Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol (2008) 1.02
The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation. Transplantation (2012) 1.00
Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider. Am J Kidney Dis (2011) 1.00
A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results. Transplantation (2008) 0.99
Kidney transplant Medicare payments and length of stay: associations with comorbidities and organ quality. Arch Med Sci (2011) 0.99
Following the organ supply: assessing the benefit of inter-DSA travel in liver transplantation. Transplantation (2013) 0.98
Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure. JAMA (2006) 0.98
Chronic inotropic therapy in end-stage heart failure. Am Heart J (2006) 0.98
Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int (2004) 0.97
Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review. Transplantation (2008) 0.96
CVD risk among men participating in the National Health and Nutrition Examination Survey (NHANES) from 2001 to 2010: differences by sexual minority status. J Epidemiol Community Health (2013) 0.96
Depression diagnoses after living kidney donation: linking U.S. Registry data and administrative claims. Transplantation (2012) 0.92
Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience. Transplantation (2006) 0.91
Prospective, pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction. Am J Transplant (2002) 0.90
Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol (2008) 0.90
Implementing a hospitalwide patient safety program for cultural change. Jt Comm J Qual Saf (2004) 0.90
Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. J Am Soc Nephrol (2004) 0.90
Electrocardiography screening for cardiotoxicity after modified Vaccinia Ankara vaccination. Am J Med (2009) 0.89
Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Clin J Am Soc Nephrol (2007) 0.89
The cost effectiveness of deceased organ donation. Transplantation (2005) 0.89
Exercise during hemodialysis decreases the use of antihypertensive medications. Am J Kidney Dis (2002) 0.89
Maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the United States. Transplantation (2005) 0.87
Occupational stress is associated with impaired work ability and reduced quality of life in patients with chronic kidney failure. Int J Artif Organs (2009) 0.87
Health-related quality of life in kidney transplant patients with diabetes. Clin Transplant (2013) 0.87
Obesity and kidney transplant candidates: how big is too big for transplantation?. Am J Nephrol (2012) 0.86
The impact of kidney transplantation on heart failure risk varies with candidate body mass index. Am Heart J (2009) 0.86
Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures. Circ Cardiovasc Qual Outcomes (2010) 0.86
Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data. Am J Nephrol (2014) 0.86
Increased risk of graft failure in kidney transplant recipients after a diagnosis of dyspepsia or gastroesophageal reflux disease. Transplantation (2008) 0.84
Gender differences in self-reported symptom awareness and perceived ability to manage therapy with disease-modifying medication among commercially insured multiple sclerosis patients. J Manag Care Pharm (2010) 0.84
Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims. Transplantation (2012) 0.84
Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosing. Am J Transplant (2004) 0.83
Renal graft survival and calcineurin inhibitor. Transplantation (2005) 0.82
Incremental value of the pancreas allograft to the survival of simultaneous pancreas-kidney transplant recipients. Diabetes Care (2009) 0.82
Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival. Clin Transpl (2008) 0.82
Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data. Transplantation (2015) 0.81
Associations of recipient illness history with hypertension and diabetes after living kidney donation. Transplantation (2011) 0.81
Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failure. Am Heart J (2008) 0.81